• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症和癌症干细胞研究模型的患者来源诱导多能干细胞。

Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.

机构信息

niChe Lab for Stem Cell and Regenerative Medicine, Department of Biochemical Science and Technology, National Taiwan University, Taiwan; Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taiwan.

niChe Lab for Stem Cell and Regenerative Medicine, Department of Biochemical Science and Technology, National Taiwan University, Taiwan.

出版信息

J Formos Med Assoc. 2018 Dec;117(12):1046-1057. doi: 10.1016/j.jfma.2018.06.013. Epub 2018 Aug 29.

DOI:10.1016/j.jfma.2018.06.013
PMID:30172452
Abstract

Induced pluripotent stem cells (iPSCs) are embryonic stem cell-like cells reprogrammed from somatic cells by four transcription factors, OCT4, SOX2, KLF4 and c-MYC. iPSCs derived from cancer cells (cancer-iPSCs) could be a novel strategy for studying cancer. During cancer cell reprogramming, the epigenetic status of the cancer cell may be altered, such that it acquires stemness and pluripotency. The cellular behavior of the reprogrammed cells exhibits dynamic changes during the different stages of reprogramming. The cells may acquire the properties of cancer stem cells (CSCs) during the process of reprogramming, and lose their carcinogenic properties during reprogramming into a cancer-iPSCs. Differentiation of cancer-iPSCs by teratoma formation or organoid culturing could mimic the process of tumorigenesis. Some of the molecular mechanisms associated with cancer progression could be elucidated using the cancer-iPSC model. Furthermore, cancer-iPSCs could be expanded in culture system or bioreactors, and serve as cell sources for research, and as personal disease models for therapy and drug screening. This article introduces cancer studies that used the cell reprogramming strategy.

摘要

诱导多能干细胞(iPSCs)是通过四个转录因子(OCT4、SOX2、KLF4 和 c-MYC)将体细胞重编程为胚胎干细胞样细胞。源自癌细胞的 iPSCs(癌症-iPSCs)可能是研究癌症的一种新策略。在癌细胞重编程过程中,癌细胞的表观遗传状态可能会发生改变,从而获得干性和多能性。在不同的重编程阶段,重编程细胞的细胞行为会发生动态变化。在重编程过程中,这些细胞可能获得癌症干细胞(CSCs)的特性,并在重编程为癌症-iPSCs 的过程中失去致癌特性。通过畸胎瘤形成或类器官培养使癌症-iPSCs 分化,可以模拟肿瘤发生的过程。可以使用癌症-iPSC 模型阐明与癌症进展相关的一些分子机制。此外,癌症-iPSCs 可以在培养系统或生物反应器中扩增,并作为研究的细胞来源,以及作为个人疾病模型进行治疗和药物筛选。本文介绍了使用细胞重编程策略进行的癌症研究。

相似文献

1
Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.用于癌症和癌症干细胞研究模型的患者来源诱导多能干细胞。
J Formos Med Assoc. 2018 Dec;117(12):1046-1057. doi: 10.1016/j.jfma.2018.06.013. Epub 2018 Aug 29.
2
Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.内源性基因的重新激活和表观遗传重塑是在猪中生成无转基因诱导多能干细胞的障碍。
PLoS One. 2016 Jun 23;11(6):e0158046. doi: 10.1371/journal.pone.0158046. eCollection 2016.
3
Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.用激活内源性启动子的四个转录因子 mRNA 诱导山羊多能干细胞。
BMC Biotechnol. 2017 Feb 13;17(1):11. doi: 10.1186/s12896-017-0336-7.
4
Reprogramming bladder cancer cells for studying cancer initiation and progression.对膀胱癌细胞进行重编程以研究癌症的起始和进展。
Tumour Biol. 2016 Oct;37(10):13237-13245. doi: 10.1007/s13277-016-5226-4. Epub 2016 Jul 25.
5
Induction of dental pulp-derived induced pluripotent stem cells in the absence of c-Myc for differentiation into neuron-like cells.在无c-Myc的情况下诱导牙髓来源的诱导多能干细胞分化为神经元样细胞。
J Chin Med Assoc. 2014 Dec;77(12):618-25. doi: 10.1016/j.jcma.2014.08.009.
6
Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.通过MYC反式激活结构域与OCT4融合提高人类体细胞重编程效率
Stem Cell Res. 2017 Dec;25:88-97. doi: 10.1016/j.scr.2017.10.014. Epub 2017 Oct 26.
7
Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).诱导机制:诱导多能干细胞(iPSCs)。
J Stem Cells. 2015;10(1):43-62.
8
Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.细胞重编程诱导多能性的转录和表观遗传机制。
Epigenomics. 2016 Aug;8(8):1131-49. doi: 10.2217/epi-2016-0032. Epub 2016 Jul 15.
9
Identification of New Transcription Factors that Can Promote Pluripotent Reprogramming.鉴定可促进多能性重编程的新转录因子。
Stem Cell Rev Rep. 2021 Dec;17(6):2223-2234. doi: 10.1007/s12015-021-10220-z. Epub 2021 Aug 26.
10
Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.用 Nanog 将小鼠成纤维细胞重编程为诱导多能干细胞。
Biochem Biophys Res Commun. 2013 Feb 15;431(3):444-9. doi: 10.1016/j.bbrc.2012.12.149. Epub 2013 Jan 16.

引用本文的文献

1
Polydatin inhibits the stemness and angiogenesis of gastric cancer cells by targeting down-regulation of HDAC7.虎杖苷通过靶向下调HDAC7抑制胃癌细胞的干性和血管生成。
Discov Oncol. 2025 May 14;16(1):761. doi: 10.1007/s12672-025-02481-8.
2
A Cross-Linked Cyclosiloxane Polymer Matrix as a Platform Enabling Long-Term Culture of Human Induced Pluripotent Stem Cells with Naïve-Like Features.一种交联环硅氧烷聚合物基质作为实现具有类原始特征的人类诱导多能干细胞长期培养的平台。
Biomater Res. 2025 Apr 28;29:0197. doi: 10.34133/bmr.0197. eCollection 2025.
3
Evaluation of the safety and efficiency of cytotoxic T cell therapy sensitized by tumor antigens original from T-ALL-iPSC in vivo.
评估源自T-ALL-iPSC的肿瘤抗原致敏的细胞毒性T细胞疗法在体内的安全性和有效性。
Cancer Innov. 2023 Oct 19;3(1):e95. doi: 10.1002/cai2.95. eCollection 2024 Feb.
4
Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy.诱导多能干细胞在类器官和细胞治疗中的应用前景
Int J Mol Sci. 2024 Feb 26;25(5):2680. doi: 10.3390/ijms25052680.
5
Interconversion of Cancer Cells and Induced Pluripotent Stem Cells.癌细胞与诱导多能干细胞的相互转化。
Cells. 2024 Jan 10;13(2):125. doi: 10.3390/cells13020125.
6
Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics.癌症干细胞在肿瘤治疗中的进展与挑战
Stem Cells Int. 2023 Dec 6;2023:8722803. doi: 10.1155/2023/8722803. eCollection 2023.
7
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.探索诱导多能干细胞在癌症研究和治疗中的广阔前景。
Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0.
8
Isolation of tumor stem-like cells from primary laryngeal squamous cell carcinoma cells (FD-LS-6).从原发性喉鳞状细胞癌细胞(FD-LS-6)中分离肿瘤干细胞样细胞。
Hum Cell. 2024 Jan;37(1):323-336. doi: 10.1007/s13577-023-00984-6. Epub 2023 Sep 27.
9
Merits and challenges of iPSC-derived organoids for clinical applications.用于临床应用的诱导多能干细胞衍生类器官的优点与挑战。
Front Cell Dev Biol. 2023 May 26;11:1188905. doi: 10.3389/fcell.2023.1188905. eCollection 2023.
10
Synergistic effects of combined cisplatin and extract on triple negative breast cancer cells.顺铂与提取物联合应用对三阴性乳腺癌细胞的协同作用。
J Taibah Univ Med Sci. 2023 Apr 15;18(6):1220-1236. doi: 10.1016/j.jtumed.2023.04.003. eCollection 2023 Dec.